Release Date: 31/01/17 20:32 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 4.83MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%